acyw135 mcv
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jul 25, 2006 (NCT06165276)
Timeline
Indications
Mechanism of action
- Neisseria meningitidisImmunity, active
Neisseria meningitidis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- acyw135 mcv
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06131554 | Phase 3 | Dec 31, 2023 | Tianjin Cansino Biotechnology Inc |
| NCT02481232 | Phase 1 | Jun 1, 2015 | China National Biotec Group Co., Ltd, People's Liberation Army of China |
| NCT06165276 | Phase 1 | Jul 25, 2006 | Sanofi-Aventis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| China National Biotec Group Co., Ltd | For profit | 1 | 1 | 1 | 2015 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2015 |
| Sanofi-Aventis | For profit | 1 | 1 | 1 | 2006 |
| Tianjin Cansino Biotechnology Inc | For profit | 1 | 1 | 1 | 2023 |
4 organizations
Page 1 / 1